Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

CONTEXT: Polycystic ovary syndrome (PCOS) is a common endocrinopathy of uncertain etiology but with strong evidence for a genetic contribution. OBJECTIVE: The objective of the study was to test the hypothesis that the typical polycystic ovarian morphology is a marker of inherited biochemical featur...

Full description

Bibliographic Details
Main Authors:	Franks, S, Webber, L, Goh, M, Valentine, A, White, D, Conway, G, Wiltshire, S, McCarthy, M
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
by: Joharatnam, J, et al.
Published: (2011)

Obesity and polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2006)

Metabolic syndrome in polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2007)

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2007)

Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
by: Franks, S, et al.
Published: (2006)

Predictors of metabolic syndrome among polycystic ovary syndrome sisters
by: Bindu Kulshreshtha, et al.
Published: (2019-01-01)

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
by: Waterworth, D, et al.
Published: (1997)

Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
by: Draper, N, et al.
Published: (2006)

Association of insulin gene VNTR polymorphism with polycystic ovary syndrome - Reply
by: Bennett, S, et al.
Published: (1997)

Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging.
by: Barber, T, et al.
Published: (2010)

Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.
by: Haddad, L, et al.
Published: (2002)

Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
by: Behnaz Enjezab, et al.
Published: (2017-11-01)

Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction
by: Ćetković Aleksandar
Published: (2008-01-01)

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

Genetic rodent models of obesity-associated ovarian dysfunction and subfertility: insights into polycystic ovary syndrome
by: Isabel eHuang-Doran, et al.
Published: (2016-06-01)

Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits.
by: Powell, B, et al.
Published: (2005)

Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
by: Kaltsas, G, et al.
Published: (2000)

Outcome of Ovarian Drilling in Women with Polycystic Ovary Syndrome
by: Niraj K Yanamandra, et al.
Published: (2015-02-01)

Polycystic ovary syndrome and circulating inflammatory markers
by: Farideh Zafari Zangeneh, et al.
Published: (2017-07-01)

Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.
by: Vassiliadi, D, et al.
Published: (2009)

The Effects of Clove Oil on The Biochemical and Histological Parameters, and Autophagy Markers in Polycystic Ovary Syndrome-Model Rats
by: Malihe Soltani, et al.
Published: (2023-04-01)

Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome
by: Cheng X, et al.
Published: (2022-04-01)

Origins and Impact of Psychological Traits in Polycystic Ovary Syndrome
by: Elisabet Stener-Victorin, et al.
Published: (2019-08-01)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
by: Youran Li, et al.
Published: (2022-06-01)

Utility of Ovarian Tumour Marker Cancer Antigen-125 and Endocrine Hormonal Status in Polycystic Ovary Syndrome
by: Shahid Akbar Mujawar, et al.
Published: (2018-10-01)

The effect of inhibin B on ovarian response in subjects with polycystic ovary
by: Affan E. Hassan, et al.
Published: (2012-04-01)

Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
by: Iason Psilopatis, et al.
Published: (2023-09-01)

Optimization of ovarian function and metabolic status in syndrome of polycystic ovaries
by: Т. Ф Татарчук, et al.
Published: (2020-05-01)

Endometrial markers of polycystic ovary syndrome (literature review)
by: E. M. Sharifulin, et al.
Published: (2017-09-01)

Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome
by: Funda Göde, et al.
Published: (2017-04-01)

Serologic markers of autoimmunity in women with polycystic ovary syndrome
by: Ahmed K. Makled, et al.
Published: (2015-06-01)

Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
by: WMM Boteju, et al.
Published: (2014-08-01)

Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome.
by: Barber, T, et al.
Published: (2008)

Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome
by: Angelique H. RIEPSAMEN, et al.
Published: (2022-09-01)

Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
by: Sebastião Freitas de Medeiros, et al.
Published: (2020-02-01)

Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms.
by: Laitinen, J, et al.
Published: (2003)

A Review on Acupuncture Efficiency in Human Polycystic Ovary/Ovarian Syndrome
by: Natália M. de Oliveira, et al.
Published: (2023-06-01)

Exercise on Ovarian Androgens and Body Composition of Women with Polycystic Ovary Syndrome
by: AA Gaeini, et al.
Published: (2012-12-01)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
by: Qingjie Peng, et al.
Published: (2023-01-01)